PUBLICATIONS FDA Decisions Expected: May 2025 Your monthly synopsis of new drugs expected to hit the market April 14, 2025 Drug pipeline for May 2025 At Prime Therapeutics (Prime), we have...

PUBLICATIONS FDA Decisions Expected: February 2025 Drug pipeline for February 2025 January 15, 2025 Your monthly synopsis of new drugs expected to hit the market At Prime Therapeutics (Prime), we...

Event features discussions about health care industry trends, best practices and innovations

publications High-Cost Therapy Profile: May 2025 Vusolimogene oderparepvec Intratumoral | Replimune Oncology-Gene therapy May 15, 2025 Proposed indications Advanced melanoma FDA approval...

Reimagine your pharmacy benefit partner Designed by health plans for health plans, we provide an innovative pharmacy benefit manager (PBM) partnership experience. Breadcrumb Home Who we are About...

Drug Approvals Monthly Update: August 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new...

publications Drug Approvals: January 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches January 31, 2025 Specialty New drugs Dec....

publications Drug Approvals: December 2024 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches December 30, 2024 Specialty New drugs...

Drug Approvals Quarterly Update: January 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process....

research 10 research posters presented by Prime at AMCP Nexus 2024 Studies include Prime’s GLP-1 obesity research, health equity, and real world case studies October 18, 2024 Evaluating the...